← Back to headlines

India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
18 Mar, 00:30 — 18 Mar, 00:30
Sources
Showing 1 of 1 sources



